Stock PSTV PLUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Plus Therapeutics, Inc.

Equities

PSTV

US72941H5090

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
2.18 USD -2.68% Intraday chart for Plus Therapeutics, Inc. +0.93% +24.56%
May. 15 Transcript : Plus Therapeutics, Inc., Q1 2024 Earnings Call, May 15, 2024
May. 09 Transcript : Plus Therapeutics, Inc. - Special Call

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike
MT
HC Wainwright Adjusts Price Target on Plus Therapeutics to $8 From $3.50, Maintains Buy Rating
MT
Maxim Adjusts Price Target on Plus Therapeutics to $12 From $30, Maintains Buy Rating
MT
JonesTrading Starts Plus Therapeutics at Buy With $5 Price Target
MT
HC Wainwright Adjusts Plus Therapeutics' Price Target to $3.50 from $7, Keeps Buy Rating
MT
PLUS THERAPEUTICS : HC Wainwright Starts Plus Therapeutics at Buy With $7 Price Target
MT
PLUS THERAPEUTICS : Ladenburg Thalmann Starts Plus Therapeutics at Buy With $8 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PSTV Stock
  4. News Plus Therapeutics, Inc.
  5. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW